Nexavar (sorafenib tosylate)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nexavar (sorafenib tosylate), covering 2013-02-26 to 2020-07-07. Get the full timeline:
Most recent: Clinical Trial Update: Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]